Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| Apellis Pharmaceuticals, Inc. | 0 | déclaré | 14 mai 2026 | tx 23+336 734−389 097 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 14 mai 2026 | TENDER | Apellis Pharmaceuticals, Inc. | 86 525 | — | |
| 14 mai 2026 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 41 250 | — | |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 41 250 | — | |
| 14 mai 2026 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 26 396 | — | |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 26 396 | — | |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 8 888 | — | |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 12 723 | — | |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 29 696 | — | |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 82 500 | — | deriv |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 49 000 | — | deriv |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 37 000 | — | deriv |
| 22 janv. 2026 | SALE | Apellis Pharmaceuticals, Inc. | 2 797 | 21.77 USD | |
| 20 janv. 2026 | SALE | Apellis Pharmaceuticals, Inc. | 1 882 | 19.79 USD | |
| 05 janv. 2026 | SALE | Apellis Pharmaceuticals, Inc. | 3 020 | 25.53 USD | |
| 09 juin 2025 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 82 500 | 19.39 USD | deriv |
| 21 janv. 2025 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 39 594 | 0.00 USD | |
| 17 janv. 2025 | SALE | Apellis Pharmaceuticals, Inc. | 1 853 | 29.96 USD | |
| 06 janv. 2025 | SALE | Apellis Pharmaceuticals, Inc. | 2 816 | 33.81 USD | |
| 16 janv. 2024 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 25 445 | 0.00 USD | |
| 16 janv. 2024 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 37 000 | 66.30 USD | deriv |
| 04 janv. 2024 | SALE | Apellis Pharmaceuticals, Inc. | 2 751 | 60.05 USD | |
| 03 janv. 2023 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 35 549 | 0.00 USD | |
| 03 janv. 2023 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 49 000 | 50.28 USD | deriv |